Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

Bird flu mRNA vaccine advances to Phase 3 testing with 4,000 participants. Discover how Moderna's H5N1 vaccine could ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

The FDA has assigned mRNA-1010 a PDUFA target date of 5 August 2026. If approved, mRNA-1010 will be the first seasonal ...